LDS/Medical Tests/Biopsy, Bladder

Biopsy, Bladder

Bladder biopsy is a procedure in which a sample of urinary bladder tissue to obtained for histopathologic examination. The indications for bladder biopsy include a variety of neoplastic and non-neoplastic conditions requiring pathologic confirmation such as urinary bladder papilloma, cystitis, urothelial dysplasia, urothelial carcinoma, adenocarcinoma, and rarely metastatic tumors. The procedure is also often performed to assess the depth of invasion for bladder carcinoma which is important for staging, prognosis, and planning the treatment.

Bladder biopsy is most commonly performed via transurethral approach (cystoscopic biopsy), although image-guided percutaneous biopsy (under CT or ultrasound guidance) is technically feasible and indicated in certain clinical conditions such as urethral strictures and tumors in the ‘cytoscopic blind spots’. Both approaches can be performed as an outpatient procedure requiring minimal anesthesia. The procedure is generally safe; potential complications include urinary tract infection, extraperitoneal or intraperitoneal hemorrhage, urinoma, tumor seeding along the biopsy tract (with percutaneous biopsy) and bladder wall rupture.

  • Evaluation of intractable cystitis
  • Diagnosis and staging of urothelial neoplasms
  • Evaluation of intramural mass lesions
Interpretation of the bladder biopsy is dependent on the clinical presentation and pathologic findings. Clinical and radiologic data are important in the interpretation of the biopsy findings. Abnormal morphologic findings are reported as pathologic diagnosis. In addition, some special stains (IHC markers) can be used for staining to support diagnostic findings.

There are no universal reference ranges for bladder biopsies. In general, bladder biopsies consist of benign urothelial mucosa and submucosal connective tissue.

Biopsies are stained with hematoxylin and eosin, and various immunohistochemical stains at the discretion of the pathologist.

Biopsies are obtained by a urologist (cystoscopic biopsies) or an interventional radiologist (percutaneous biopsies) under ultrasound or CT guidance. Routine specimens are placed directly in formalin fixative and sent to histopathologic examination. When culture is indicated (suspected infectious causes), the specimen is placed in a sterile container for microbiologic assessment.

Urine cytology; UroVysion to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH), Bladder Tumor Associated Antigen, Urinalysis and urine cytology, cystoscopic examination, PSA (total), Nuclear Matrix Proteins (NMP22), Ki-67 and p53 Tissue Assay, p21 (Waf1/Cip 1), p16, Cytokeratin 5,6 (CK 5,6) by Immunohistochemistry.
Usually 24 hours for routine light microscopy, longer for immunohistochemical stains, which varies from case to case.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login